ResearcherJiangsu UniversityActive in the last 2 years
Huizhi Wang
Matched on ORCID iD 0000-0002-9666-9387; OpenAlex author ID A5102005197. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 4
- Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer. First author DOI 10.7150/jca.88397↗
- Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signaling. Co-author DOI 10.7150/jca.81320↗
- The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let-7i/TET3 pathway. Co-author DOI 10.1002/1878-0261.12836↗
- PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. First author DOI 10.1111/jcmm.14894↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aihua Gong · 3 shared papers, 2020–2023 · strength 0.42
- Paper Hypoxia-elicited Exosomes Promote the Chemoresistance of Pancreatic Cancer Cells by Transferring LncROR via Hippo Signa… DOI 10.7150/jca.81320↗
- Paper The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let-7i/TET3 pathway. DOI 10.1002/1878-0261.12836↗
- Paper PRMT5 promotes epithelial-mesenchymal transition via EGFR-β-catenin axis in pancreatic cancer cells. DOI 10.1111/jcmm.14894↗
- Youli Zhang · 2 shared papers, 2020–2021 · strength 0.23
- Min Xu · 2 shared papers, 2020–2021 · strength 0.23
- Qi Wang · 1 shared paper, 2024 · strength 0.23
- Yuntao Ding · 1 shared paper, 2024 · strength 0.23
- Min Xu · 1 shared paper, 2024 · strength 0.23
- Min Xu · 1 shared paper, 2023 · strength 0.19
- Yawen Liu · 1 shared paper, 2021 · strength 0.12
- Jingyu Min · 1 shared paper, 2021 · strength 0.12
- Wan‐Xin Peng · 1 shared paper, 2020 · strength 0.11
- Lu Ge · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.